AFYREN (90N) Price & Analysis
90N Stock Chart & Stats
- Day’s Range
- EUR 2.24 - EUR 2.24
- 52-Week Range
- EUR 2.05 - EUR 3.05
- Previous Close
- EUR 2.23
- Volume
- 0
- Average Volume (3M)
- 1
- Market Cap
- EUR 87.81M
- Enterprise Value
- EUR 122.72M
- Total Cash (Recent Filing)
- EUR 17.30M
- Total Debt (Recent Filing)
- EUR 40.90M
- Price to Earnings (P/E)
- ―
- Beta
- 0.04
- Next Earnings
- Mar 24, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Financial Leverage
Meaningfully reduced debt and low leverage give AFYREN greater financial flexibility than its losses alone would suggest. This balance-sheet capacity can help the company fund operations, absorb volatility, and pursue industrial scaling while limiting pressure from interest and refinancing obligations.
Proprietary Bio-based Platform
The proprietary fermentation platform addresses demand for renewable chemical inputs while using non-food biomass and organic residues. Its products target several end markets and are intended as substitutes for petroleum-derived chemicals, supporting a potentially durable industrial opportunity.
Prior Gross-profit Capability
Positive gross profit in earlier years shows that AFYREN has previously demonstrated some ability to create product-level economic value. If production utilization and operating execution improve, that historical capability could support a path toward better margins, although it is not currently sustained.
Bears Say
Declining Revenue
Two consecutive years of substantial revenue contraction indicate that commercial growth and plant or customer ramp-up have not yet produced a durable expansion in sales. Continued decline would reduce operating leverage, weaken scale benefits, and make recovery toward sustainable profitability more difficult.
Deepening Unprofitability
The widening net loss and reversal to a large gross loss show that the current cost structure is not supporting profitable operations. Persistent losses can erode equity over time, constrain investment capacity, and increase the importance of successful industrial execution and revenue recovery.
Persistent Cash Burn
Consistently negative operating and free cash flow means AFYREN is not yet self-funding its business. Even though free cash flow improved modestly in 2025, ongoing cash consumption can raise financing needs and limit the company’s ability to scale without using its balance-sheet resources.
90N FAQ
What was AFYREN’s price range in the past 12 months?
What is AFYREN’s market cap?
When is AFYREN’s upcoming earnings report date?
How were AFYREN’s earnings last quarter?
Is AFYREN overvalued?
Does AFYREN pay dividends?
What is AFYREN’s EPS estimate?
How many shares outstanding does AFYREN have?
What happened to AFYREN’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AFYREN?
What is the TipRanks Smart Score and how is it calculated?
Company Description
AFYREN
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Nicolas Sordet
- Employees
- 149
- Website
- afyren.com
- Address
- 9-11 rue Gutenberg, Clermont-Ferrand, ARA, 63100, FR
AFYREN (90N) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 6 | 10 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 4 | 0 | 8 |